Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

ENDRA Life Sciences (NDRA) Invested Capital (2016 - 2025)

ENDRA Life Sciences has reported Invested Capital over the past 6 years, most recently at $11.3 million for Q4 2021.

  • Quarterly Invested Capital rose 45.67% to $11.3 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $11.3 million through Dec 2021, up 45.67% year-over-year, with the annual reading at $11.3 million for FY2021, 45.67% up from the prior year.
  • Invested Capital was $11.3 million for Q4 2021 at ENDRA Life Sciences, down from $13.2 million in the prior quarter.
  • Over five years, Invested Capital peaked at $17.9 million in Q1 2021 and troughed at -$1.4 million in Q1 2017.
  • The 5-year median for Invested Capital is $4.3 million (2019), against an average of $5.7 million.
  • Year-over-year, Invested Capital plummeted 106.38% in 2018 and then surged 1434.47% in 2021.
  • A 5-year view of Invested Capital shows it stood at $5.3 million in 2017, then increased by 18.44% to $6.2 million in 2018, then decreased by 23.81% to $4.8 million in 2019, then surged by 63.39% to $7.8 million in 2020, then surged by 45.67% to $11.3 million in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Invested Capital are $11.3 million (Q4 2021), $13.2 million (Q3 2021), and $15.0 million (Q2 2021).